REvenue guidance is up from pro forma $30m based on a full year of scanmedics, to $30 to 33m - which includes 9 months. However EBITDA has gone from proforma $4m (12mnth) to $3.5 to 4m (9mnth). About the same I guess.
REvenue guidance is up from pro forma $30m based on a full year...
Add PGC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
-0.010(2.08%) |
Mkt cap ! $777.9M | |||
| Open | High | Low | Value | Volume |
| 47.5¢ | 47.5¢ | 45.5¢ | $101.9K | 218.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 97093 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.0¢ | 13527 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PGC (ASX) Chart |